Patents by Inventor Jane Ruman

Jane Ruman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240009278
    Abstract: The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.
    Type: Application
    Filed: May 5, 2023
    Publication date: January 11, 2024
    Applicant: FERRING B.V.
    Inventors: Joan-Carles ARCE, Jane RUMAN, Patrick HEISER
  • Patent number: 11679145
    Abstract: The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: June 20, 2023
    Assignee: FERRING B.V.
    Inventors: Joan-Carles Arce, Jane Ruman, Patrick Heiser
  • Patent number: 11351228
    Abstract: The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: June 7, 2022
    Assignee: FERRING B.V.
    Inventors: Joan-Carles Arce, Jane Ruman
  • Publication number: 20210093697
    Abstract: The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.
    Type: Application
    Filed: December 10, 2020
    Publication date: April 1, 2021
    Applicant: FERRING B.V.
    Inventors: Joan-Carles Arce, Jane Ruman, Patrick Heiser
  • Publication number: 20200093893
    Abstract: The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.
    Type: Application
    Filed: August 29, 2019
    Publication date: March 26, 2020
    Applicant: FERRING B.V.
    Inventors: Joan-Carles Arce, Jane Ruman
  • Patent number: 10413592
    Abstract: The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: September 17, 2019
    Assignee: FERRING B.V.
    Inventors: Joan-Carles Arce, Jane Ruman
  • Publication number: 20160250296
    Abstract: The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.
    Type: Application
    Filed: February 25, 2016
    Publication date: September 1, 2016
    Applicant: FERRING B.V.
    Inventors: Joan-Carles Arce, Jane Ruman